Alnylam Europe AG
Patent Applications and Registrations
Patent applications and USPTO patent grants for Alnylam Europe AG.The latest application filed is for "compositions and methods for inhibiting expression of anti-apoptotic genes".
- Alnylam Europe AG - Cambridge MA
- Alnylam Europe AG - Kulmbach DE
- Alnylam Europe AG -
| Patent | Date |
|---|---|
| Compositions and methods for inhibiting expression of anti-apoptotic genes Grant 7,473,525 - Kreutzer , et al. January 6, 2 | 2009-01-06 |
| Compositions and methods for inhibiting viral replication Grant 7,348,314 - John , et al. March 25, 2 | 2008-03-25 |
| Double-stranded RNA (DSRNA) and method of use for inhibiting expression of the AML-1/MTG8 fusion gene Grant 7,196,184 - Heidenreich , et al. March 27, 2 | 2007-03-27 |
| Compositions and methods for inhibiting expression of anti-apoptotic genes App 20050176667 - Vornlocher, Hans-Peter | 2005-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 